Does Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues?

Simply Wall St.04-24 17:12

Recently, Axion BioSystems announced that it had reached a confidential settlement with Agilent Technologies to fully resolve two Delaware lawsuits, with neither party admitting liability and Axion ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2629933817?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/154924-main-header/1756254020530","is_english":true,"pubTime":"2026-04-24 17:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2629933817","market":"hk","top_or_hot":-1,"title":"Does Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues?","media":"Simply Wall St.","content":"<div>\n<p>Recently, Axion BioSystems announced that it had reached a confidential settlement with Agilent Technologies to fully resolve two Delaware lawsuits, with neither party admitting liability and Axion ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/does-agilent-a-settling-axion-dispute-clarify-its-push-into\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Does Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoes Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-24 17:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/does-agilent-a-settling-axion-dispute-clarify-its-push-into><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Recently, Axion BioSystems announced that it had reached a confidential settlement with Agilent Technologies to fully resolve two Delaware lawsuits, with neither party admitting liability and Axion ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/does-agilent-a-settling-axion-dispute-clarify-its-push-into\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"A","symbol_name":"安捷伦科技","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/does-agilent-a-settling-axion-dispute-clarify-its-push-into","article_id":"2629933817","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/154924-main-header/1756254020530"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/does-agilent-a-settling-axion-dispute-clarify-its-push-into","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2629933817","pubTimestamp":1777021966,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Recently, Axion BioSystems announced that it had reached a confidential settlement with Agilent Technologies to fully resolve two Delaware lawsuits, with neither party admitting liability and Axion continuing to market and develop its product line.\nAt the same time, industry research highlights Agilent as an important provider in the expanding Cloud Electronic Laboratory Notebook market, where digitalization and compliance needs are driving broader adoption of cloud-based lab data...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"A":"安捷伦科技"},"translate_title":"安捷伦(A)解决Axion纠纷是否澄清了其进军云实验室数据经常性收入的努力？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"A":1.5},"content_text":"Recently, Axion BioSystems announced that it had reached a confidential settlement with Agilent Technologies to fully resolve two Delaware lawsuits, with neither party admitting liability and Axion continuing to market and develop its product line. At the same time, industry research highlights Agilent as an important provider in the expanding Cloud Electronic Laboratory Notebook market, where digitalization and compliance needs are driving broader adoption of cloud-based lab data platforms. Next, we’ll examine how resolving the Axion litigation could influence Agilent’s investment narrative around recurring software and data-management revenues. Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.AdvertisementAgilent Technologies Investment Narrative RecapTo own Agilent, you need to believe in its role as a core supplier of lab instruments and data platforms, with growing exposure to software and services. The Axion settlement looks immaterial to near term fundamentals, but it removes a legal overhang at a time when competitive intensity and reliance on capital equipment cycles remain key risks to watch. The clearest link to this development is Agilent’s push into cloud-based Electronic Laboratory Notebook solutions, where it is cited as an important provider. As labs modernize digital workflows and compliance, this area ties directly into the company’s push for higher margin, recurring software and data management revenues, which many investors see as an important offset to tariff pressures and capital spending cyclicality. Yet while the Axion issue is resolved, investors should be aware that rising global tariffs and supply chain complexity could still... Read the full narrative on Agilent Technologies (it's free!)Agilent Technologies' narrative projects $8.6 billion revenue and $2.0 billion earnings by 2029.Uncover how Agilent Technologies' forecasts yield a $161.94 fair value, a 42% upside to its current price.Exploring Other PerspectivesA 1-Year Stock Price Chart Five fair value estimates from the Simply Wall St Community span roughly US$124.64 to US$161.94 per share, underlining how far apart individual views can be. You may want to weigh these opinions against the risk that higher tariffs and supply chain disruption could pressure margins and influence how Agilent’s performance unfolds over time.Explore 5 other fair value estimates on Agilent Technologies - why the stock might be worth as much as 42% more than the current price!The Verdict Is YoursDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your Agilent Technologies research is our analysis highlighting 4 key rewards that could impact your investment decision.Our free Agilent Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Agilent Technologies' overall financial health at a glance.No Opportunity In Agilent Technologies?Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:Find 54 companies with promising cash flow potential yet trading below their fair value.We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2629933817","isCrawlerRequest":true}